References
- 1. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. [Internet]. 2013 [cited 2017 Oct 31];14:681-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23999272.10.1038/nrg355523999272
- 2. Boycott KM, Rath A, Chong JX, Hartley T, Alkuraya FS, Baynam G, et al. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases. Am. J. Hum. Genet. [Internet]. 2017 [cited 2017 Oct 31];100:695-705. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28475856.10.1016/j.ajhg.2017.04.003542035128475856
- 3. Evangelista T, Hanna M, Lochmüller H. Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness. Lochmüller H, editor. J. Neuromuscul. Dis. [Internet]. 2015 [cited 2017 Oct 30];2:S21-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26870666.10.3233/JND-150098474674626870666
- 4. Sun W, Zheng W, Simeonov A. Drug discovery and development for rare genetic disorders. Am. J. Med. Genet. Part A [Internet]. 2017 [cited 2017 Oct 31];173:2307-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28731526.10.1002/ajmg.a.38326566212928731526
- 5. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. [Internet]. IOP Publishing; 2015;17:405-23. Available from: http://dx.doi.org/10.1038/gim.2015.30.10.1038/gim.2015.30454475325741868
- 6. Mattassi R, Manara E, Colombo PG, Manara S, Porcella A, Bruno G, et al. Variant discovery in patients with Mendelian vascular anomalies by next-generation sequencing and their use in patient clinical management. J. Vasc. Surg. [Internet]. 2017 [cited 2017 Jul 31]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/28655553.